Eslicarbazepine acetate is primarily used in the treatment of epilepsy, specifically for managing partial-onset seizures. It is an anticonvulsant that works by stabilizing the electrical activity in the brain, preventing the excessive firing of neurons that leads to seizures. This medication is often prescribed for adults who require adjunctive therapy when their current treatment regimen is not fully effective. It is administered orally, typically in tablet form, and is designed to be taken once daily, which can improve patient compliance. Eslicarbazepine acetate is particularly valued for its ability to reduce seizure frequency with a relatively favorable side effect profile compared to some other antiepileptic drugs. It is also being studied for potential use in other neurological conditions, though its primary application remains in epilepsy management.